Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 9/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | CASP1 | P29466 | 2/20 | 0.46 |
| ▸ | CASP7 | P55210 | 2/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 4/20 | 0.43 |
| ▸ | RAB9A | P51151 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | TTR | P02766 | 2/20 | 0.39 |
| ▸ | KDM5A | P29375 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12608758 | 0.82 | MAOA (0.47) | MAOAKDM4EALDH1A1MAPTCASP1 | |
| SCHEMBL12608767 | 0.78 | PTGS2 (0.48) | PTGS2MAOAKDM4EALDH1A1MAPT | |
| SCHEMBL12608761 | 0.77 | CYP1A2 (0.38) | KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL12608763 | 0.72 | MAOA (0.50) | MAOAKDM4EALDH1A1MAPTCASP1 | |
| SCHEMBL12608777 | 0.70 | CYP1A2 (0.57) | PTGS2MAOAKDM4EALDH1A1MAPT | |
| SCHEMBL8563345 | 0.70 | MAOA (0.42) | PTGS2MAOAKDM4EALDH1A1MAPT | |
| Xanthone SCHEMBL5376736 | 0.69 | MAOA (0.95) | PTGS2MAOAKDM4EALDH1A1MAPT | |
| SCHEMBL12608843 | 0.69 | CYP2B6 (0.39) | — | |
| SCHEMBL9836636 | 0.69 | PTGS2 (0.47) | PTGS2MAOAKDM4EALDH1A1MAPT | |
| SCHEMBL1324122 | 0.68 | PTGS2 (0.57) | PTGS2MAOAKDM4EALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8323750-B2 | Method of ultraviolet light assisted surface modification and product having a surface formed by this method | BEIJING WANHEXINYUAN BIOTECHNOLOGY CO., LTD. (CN) | 2012-12-04 | — | — | US | disclosed |
| US-8323750-B2 | Method of ultraviolet light assisted surface modification and product having a surface formed by this method | BEIJING WANHEXINYUAN BIOTECHNOLOGY CO., LTD. (CN) | 2012-12-04 | — | — | US | disclosed |
| US-20110124766-A1 | METHOD OF ULTRAVIOLET LIGHT ASSISTED SURFACE MODIFICATION AN PRODUCT HAVING A SURFACE FORMED BY THIS METHOD | BEIJING WANHEXINYUAN BIOTECHNOLOGY CO., LTD. (CN) | 2011-05-26 | — | — | US | disclosed |
| US-20110124766-A1 | METHOD OF ULTRAVIOLET LIGHT ASSISTED SURFACE MODIFICATION AN PRODUCT HAVING A SURFACE FORMED BY THIS METHOD | BEIJING WANHEXINYUAN BIOTECHNOLOGY CO., LTD. (CN) | 2011-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110124766-A1 | METHOD OF ULTRAVIOLET LIGHT ASSISTED SURFACE MODIFICATION AN PRODUCT HAVING A SURFACE FORMED BY THIS METHOD | XPA, CYBA, PROC | PTGS2 3328/4885MAOA 34/4885KDM4E 1160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.